e-learning
resources
Conferences
Lung Science Conference
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oral presentation: Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/ remodelling in emphysema
L.S. Mackay, L.A. Borthwick, K. Pinnion, C. Ward, J. Lordan, M. Foster, A.J. Fisher, P.A. Corris (Newcastle upon Tyne, United Kingdom)
Source:
Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Number:
19
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L.S. Mackay, L.A. Borthwick, K. Pinnion, C. Ward, J. Lordan, M. Foster, A.J. Fisher, P.A. Corris (Newcastle upon Tyne, United Kingdom). Oral presentation: Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/ remodelling in emphysema. Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/remodelling in emphysema
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
Source: Eur Respir J, 56 (4) 2003167; 10.1183/13993003.03167-2020
Year: 2020
Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT)
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 39: 133-140
Year: 2012
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 133-140
Year: 2012
Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
Alveolar epithelial injury and apoptosis
Source: Annual Congress 2007 - Mechanisms in pulmonary fibrosis
Year: 2007
Apoptosis of alveolar septal cells contributes to the pathogenesis of emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype
Source: Eur Respir Rev 2014; 23: 118-130
Year: 2014
The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Impaired tissue repair in emphysema: intrinsic defects in mesenchymal stromal cells or defects in the matrix?
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017
PDGFRa and aSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Altered proliferation of alveolar epithelial cells is involved in progressive elastase-induced emphysema
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021
Alveolar epithelial cell plasticity in lung injury, repair and fibrosis
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept